Search Within

Anthony R Mato

Formats
  1. Meeting Abstract (135)
  2. Journal Article (63)
  3. Review (16)
  4. Research Letter (10)
  5. Editorial (7)
  6. Guidelines (3)
  7. Book Section (1)
  8. Miscellaneous (1)
Groups
  1. Adult Leukemia (236)
  2. Center for Hematologic Malignancies (236)
  3. Department of Medicine (236)
  4. Hematologic Malignancies, Division of (236)
  5. Hematology-Oncology Fellows (101)
  6. Lymphoma (47)

More Groups

People
  1. Lindsey Roeker (94)
  2. Andrew Zelenetz (33)
  3. Meghan Thompson (30)
  4. Omar Abdel-Wahab (19)
  5. Maria Palomba (18)
  6. Colleen Dorsey (14)

More People

Years
  1. 2025 (4)
  2. 2024 (2)
  3. 2023 (22)
  4. 2022 (49)
  5. 2021 (39)
  6. 2020 (52)

More Years

Publications
  1. Blood (82)
  2. Journal of Clinical Oncology (18)
  3. Clinical Lymphoma, Myeloma and Leukemia (16)
  4. Leukemia and Lymphoma (16)
  5. British Journal of Haematology (15)
  6. Blood Advances (10)

More Publications

Publishers
  1. American Society of Hematology (94)
  2. American Society of Clinical Oncology (19)
  3. Elsevier Inc. (18)
  4. Taylor & Francis Group (18)
  5. John Wiley & Sons (16)
  6. American Association for Cancer Research (10)

More Publishers

Results (236)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evidence for and against green tea and turmeric in the management of chronic lymphocytic leukemia
    Journal Article

    Bange, E.; Timlin, C.; Kabel, C.; Svoboda, J.; Roeker, L.; Mato, A. R.
    Clinical Lymphoma, Myeloma and Leukemia (2018)

    Fulltext@MSK | Save
  • Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era
    Journal Article

    Mato, A.; Jahnke, J.; Li, P.; Mehra, M.; Ladage, V. P.; Mahler, M.; Huntington, S.; Doshi, J. A.
    Haematologica (2018)

    Fulltext@MSK | Save
  • Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial
    Journal Article

    Mato, A. R.; Roeker, L. E.; Allan, J. N.; Pagel, J. M.; Brander, D. M.; Hill, B. T.; Cheson, B. D.; Furman, R. R.; Lamanna, N.; Tam, C. S.; more...
    American Journal of Hematology (2018)

    Fulltext@MSK | Save
  • Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States
    Journal Article

    Mato, A. R.; Thompson, M.; Allan, J. N.; Brander, D. M.; Pagel, J. M.; Ujjani, C. S.; Hill, B. T.; Lamanna, N.; Lansigan, F.; Jacobs, R.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Drivers of treatment patterns in patients with chronic lymphocytic leukemia stopping ibrutinib or idelalisib therapies
    Journal Article

    Mato, A. R.; Samp, J. C.; Gauthier, G.; Terasawa, E.; Brander, D. M.
    Cancer Biology and Therapy (2018)

    Fulltext@MSK | Save
  • Immunotherapy for the treatment of Hodgkin lymphoma: An evolving paradigm
    Journal Article

    Bair, S. M.; Mato, A.; Svoboda, J.
    Clinical Lymphoma, Myeloma and Leukemia (2018)

    Fulltext@MSK | Save